GOLD 2011 disease severity classification in COPDGene: A prospective cohort study

The Lancet Respiratory Medicine

Volumn 1, Issue 1, 2013, Pages 43-50

  Han, MeiLan K ^a   Muellerova, Hana ^b   Curran Everett, Douglas ^c   Dransfield, Mark T ^d   Washko, George R ^e   Regan, Elizabeth A ^c   Bowler, Russell P ^c   Beaty, Terri H ^f   Hokanson, John E ^g   Lynch, David A ^c   Jones, Paul W ^h   Anzueto, Antonio ⁱ   Martinez, Fernando J ^a   Crapo, James D ^c   Silverman, Edwin K ^e   Make, Barry J ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c DEPARTMENT OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

ⁱ UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL SCALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; CLASSIFICATION; CLINICAL TRIAL; FORCED EXPIRATORY VOLUME; HEALTH STATUS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

AGED; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 84877102716     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(12)70044-9     Document Type: Article

References (24)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555. the Global Initiative for Chronic Obstructive Lung Disease.
2. Weatherall M, Marsh S, Shirtcliffe P, Williams M, Travers J, Beasley R Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J 2009, 33:1025-1030.
3. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 363:1128-1138. the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.
4. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010, 11:122. the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators.
5. Global Initiative for Chronic Obstructive Lung Disease Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, (accessed April 4, 2012). http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html.
6. Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010, 7:32-43.
7. Brooks S Surveillance for respiratory hazards. ATS News 1982, 8:12-16.
8. Jones PW, Quirk FH, Baveystock CM The St George's Respiratory Questionnaire. Respir Med 1991, 85(suppl B):25-31.
9. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ 1959, 2:257-266.
10. Jones PW, Brusselle G, Dal Negro RW, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011, 38:29-35.
11. Jones PW, Tabberer M, Chen WH Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med 2011, 11:42.
12. Ferris BG Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 1978, 118:1-120.
13. 1994 Update. Am J Respir Crit Care Med 1995, 152:1107-1136. American Thoracic Society.
14. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:1005-1012.
15. Jones PW, Quirk FH, Baveystock CM, Littlejohns P A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
16. Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest 2007, 132:1283-1290.
17. Mahler DA, Ward J, Waterman LA, McCusker C, Zuwallack R, Baird JC Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest 2009, 136:1473-1479.
18. 1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res 2011, 12:40.
19. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N Development and first validation of the COPD Assessment Test. Eur Respir J 2009, 34:648-654.
20. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775-789. the TORCH investigators.
21. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554. the UPLIFT Study Investigators.
22. Dodd JW, Marns PL, Clark AL, et al. The COPD Assessment Test (CAT): short- and medium-term response to pulmonary rehabilitation. COPD 2012, published online April 12. 10.3109/15412555.2012.671869.
23. Jones PW, Harding G, Wiklund I, et al. Tests of the responsiveness of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test TM (CAT) following acute exacerbation and pulmonary rehabilitation. Chest 2012, 142:134-140.
24. Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012, 185:1218-1224.